Tricyclic sulfonamides and their derivatives as inhibitors...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/04 (2006.01) A61K 31/34 (2006.01) A61K 31/38 (2006.01) C07C 311/21 (2006.01) C07D 209/88 (2006.01) C07D 307/91 (2006.01) C07D 307/93 (2006.01) C07D 333/76 (2006.01)

Patent

CA 2335077

Tricyclic sulfonamide compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurysm, heart failure, left ventricular dilation, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation, pain, arthritis, osteoporosis, renal disease, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes or other activated migrating cells, acute and chronic neurodegenerative disorders including stroke, head trauma, spinal cord injury, Alzheimer's disease, amyotrophic lateral sclerosis, cerebral amyloid angiopathy, AIDS, Parkinson's disease, Huntington's disease, prion diseases, myasthenia gravis, and Duchenne's muscular dystrophy.

Cette invention se rapporte à des composés sulfonamides tricycliques et à des dérivés de ces composés, ainsi qu'à des procédés de préparation et des compositions pharmaceutiques de ces composés, qui sont utiles comme inhibiteurs des métalloprotéinases matricielles, notamment la gélatinase A, la collagénase-3 et la stromélysine-1, et qui servent à traiter la sclérose en plaques, les ruptures de la plaque d'athérosclérose, les anévrismes de l'aorte, les défaillances cardiaques, la dilatation ventriculaire gauche, les resténoses, les affections parodontales, l'ulcération de la cornée, le traitement des brûlures, les ulcères de décubitus, la cicatrisation des plaies, les cancers, les inflammations, les douleurs, l'arthrite, l'ostéoporose, les affections rénales ou d'autres affections auto-immunes ou inflammatoires qui dépendent de l'invasion des tissus par les leucocytes ou par d'autres cellules migratrices activées, les troubles neurodégénératifs aigus et chroniques, y compris les attaques, les traumatismes crâniens, les lésions de la colonne vertébrale, la maladie d'Alzheimer, la sclérose latérale amyotrophique, l'angiopathie amyloïde cérébrale, le SIDA, la maladie de Parkinson, la maladie de Huntington, les maladies à prions, les myasthénies aiguës et la dystrophie musculaire de Duchenne.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic sulfonamides and their derivatives as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic sulfonamides and their derivatives as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic sulfonamides and their derivatives as inhibitors... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2016094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.